US 10166288
Vaccines having an antigen and interleukin-21 as an adjuvant
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 10166288 (Vaccines having an antigen and interleukin-21 as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K39/08, A61K39/12